200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 569329-55-1
CAS No: 569329-55-1 Catalog No: AG00F2L2 MDL No:
| Title | Journal |
|---|---|
| Ground and excited electronic states of quininone-containing Re(I)-based rectangles: a comprehensive study of their preparation, electrochemistry, and photophysics. | Inorganic chemistry 20090420 |
| A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR. | Journal of medicinal chemistry 20050421 |
| Electrodes modified with monoolein cubic phases hosting laccases for the catalytic reduction of dioxygen. | Analytical chemistry 20040115 |
| Metabolism and elimination of quinine in healthy volunteers. | European journal of clinical pharmacology 20030901 |
| Nuclear overexpression of NADH:cytochrome b5 reductase activity increases the cytotoxicity of mitomycin C (MC) and the total number of MC-DNA adducts in Chinese hamster ovary cells. | The Journal of biological chemistry 20030214 |
| Simultaneous determination of quinine and four metabolites in plasma and urine by high-performance liquid chromatography. | Journal of chromatography. B, Biomedical sciences and applications 20010415 |
| Development of a pharmacophore for inhibition of human liver cytochrome P-450 2D6: molecular modeling and inhibition studies. | Journal of medicinal chemistry 19930430 |
© 2019 Angene International Limited. All rights Reserved.